Holen Sie sich die Stockscreener-App
8.49
8.81%
-0.82
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 1.292 | 1.09 | 1.46 |
| Operating Expenses |
1.60%
20.11
|
20.44 | 51.69 | 20.33 | 28.66 |
| Operating Income/Loss |
1.60%
-20.11
|
-20.44 | -50.40 | -19.24 | -27.20 |
| Income/Loss From Continuing Operations Before Tax |
3.70%
-18.81
|
-19.53 | -49.41 | -18.06 | -25.77 |
| Income Tax Expense/Benefit |
13.68%
0.108
|
0.095 | 0.636 | - | 0.001 |
| Net Income/Loss |
3.61%
-18.92
|
-19.62 | -50.04 | -18.06 | -25.77 |
| Basic Average Shares |
51.90%
17.62
|
11.60 | - | 9.3916 | 9.3905 |
| Diluted Average Shares |
51.90%
17.62
|
11.60 | - | 9.3916 | 9.3905 |
| Basic Earnings Per Share |
36.69%
-1.07
|
-1.69 | - | -1.92 | -2.74 |
| Diluted Earnings Per Share |
36.69%
-1.07
|
-1.69 | - | -1.92 | -2.74 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):